News story

Andrew Witty appointed as BIS Lead Non-Executive Board Member

This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government

Andrew Witty, the chief executive of GlaxoSmithKline, will take up his position on the new Departmental Board from 1 January 2011. The Board…